Immediate Impact
55 standout
Citing Papers
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Works of Nina Horowitz being referenced
Features of triple-negative breast cancer
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Nina Horowitz | 661 | 615 | 337 | 49 | 1.4k | |
| Lukas Schwentner | 486 | 523 | 235 | 78 | 1.3k | |
| Linda de Munck | 909 | 943 | 456 | 77 | 1.6k | |
| Nancy Roach | 300 | 773 | 357 | 35 | 1.7k | |
| J. Frank Wilson | 575 | 510 | 265 | 80 | 1.5k | |
| Oluwadamilola M. Fayanju | 857 | 761 | 443 | 106 | 1.6k | |
| W. van de Water | 756 | 854 | 220 | 37 | 1.3k | |
| Kathleen M. Diehl | 788 | 504 | 569 | 48 | 1.6k | |
| Lola A. Fashoyin‐Aje | 315 | 990 | 207 | 65 | 1.7k | |
| Arduino Verdecchia | 283 | 953 | 280 | 35 | 1.5k | |
| Olive Kearins | 862 | 875 | 446 | 56 | 1.6k |
All Works
Loading papers...